About Primity Bio
Primity Bio is a Healthcare company based in Santa Clara (United States) founded in 2008 by Peter Krutzik, and was acquired by CellCarta in August 2018. Multi-parameter cell analysis systems are developed for high-content screening. Its chief executive, as recorded, is Peter Krutzik. Primity Bio offers products and services including Biomarker Services, Genomics Services, Histopathology Services, Immune Monitoring, and Lab Logistics Services. Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Research Assays and Drug Discovery. Its competitors include Rheonix, 64x Bio and Modular Genetics; 3 of its 3 listed competitors have raised funding.
Company details
PrimityBio has developed a flowcytometry-based, multiparameter cell analysis system for high content screening with a focus on drug discovery applications. The companys platform performs single cell analysis at more than 10 parameters or markers per cell, at a rate of 5000 cells per second, with sensitivity in the range of 50 molecules per cell. Coupled with automation, the system can screen through 2000 compound wells per day to generate over 100,000 data points. The company also provides the Cytobank flow cytometry software which can analyze the generated data. The systems instrumentation includes a choice of flow cytometers (4, 5 and 6 laser BD LSR II flow cytometers with HTS sample units and up to 19 fluorescent channels, Fluidigm CyTOF Helios Mass Cytometer, BD Aria II Cell Sorter, Agilent VWorks-based automation platform, etc.
Products & Services of Primity Bio
Primity Bio offers a comprehensive portfolio of products and services, including Biomarker Services, Genomics Services, Histopathology Services, Immune Monitoring, and Lab Logistics Services.
Analyzes clinical biomarkers for drug development applications
Provides digital PCR and RNA sequencing for research
Offers digital pathology and IHC solutions for diagnostics
Conducts assays like FACS for cellular phenotyping
Manages sample handling and biorepository solutions
Apps and channels of Primity Bio
its YouTube channel CellCarta has 72 subscribers and 9 videos.
Videos from Primity Bio
The most watched videos on Primity Bio's YouTube channel, CellCarta (72 subscribers). Click a video to play it here.
More on CellCarta.
Funding Insights of Primity Bio
- Total Rounds 9
- Last Round Grant — $1.5M
- First Round $101,358
(Apr 2008)
- Investors Count 1
All 9 funding rounds of Primity Bio with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
2 investors in total: 2 institutional.
Investors in Primity Bio
Primity Bio has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include HHS and CellCarta.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Public health and human services are overseen by HHS. | 1953 | hhs.gov | ||
Histopathology and genomics services are offered by the CRO. | 2000 | cellcarta.com | Montreal, Canada |
Investor details for Primity Bio
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Primity Bio
27 people are tracked at Primity Bio (10 in leadership, 15 in board & advisors, 2 in team).
| Name | Role | Group |
|---|---|---|
Peter Krutzik | Founder & CEO | Leadership |
Dusty Tenney | CEO | Leadership |
Nancy El Sayegh | VP, General Counsel & Corporate Secretary | Leadership |
Christopher Ung | Chief Scientific Business Officer | Leadership |
Hayden Routledge | Global Chief Commercial Officer | Leadership |
Anthony Mattacchione | Global Chief Financial Officer | Leadership |
Todd Chermak | Chief Regulatory & Government Affairs Officer | Leadership |
Mark Kockx | Chief Scientific Officer & Medical Director | Leadership |
Lorella Di Donato | COO, Immunology & Proteomics Divisions | Leadership |
Kristien Verhoeven | COO, HistoCarta & GeneCarta | Leadership |
David Spaight | Chairman | Board & advisors |
Steve McLean | Director | Board & advisors |
Eugene Gorbach | Director | Board & advisors |
William Castell | Director | Board & advisors |
Martin Leblanc | Co-Founder & Vice-Chairman | Board & advisors |
Pascale Witz | Director | Board & advisors |
Garry Nolan | Scientific Advisor | Board & advisors |
Rafick - Pierre Sékaly | Scientific Advisor | Board & advisors |
Scott Gottlieb | Scientific Advisor | Board & advisors |
Jedd D. Wolchok | Scientific Advisor | Board & advisors |
7 more people are available in the full profile.
Complete people profiles for Primity Bio
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Primity Bio
4 dated milestones of Primity Bio across 10 years, from founding to its latest funding, stage changes and deals.
- Founded Primity Bio is founded.
- Funding First funding round of $101K.
- Funding Latest funding round, Grant, of $1.5M.
- Exit Acquired by CellCarta.
Competitors of Primity Bio
Primity Bio has 3 listed competitors in our database, 3 of them funded. They include Rheonix, 64x Bio and Modular Genetics.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| rheonix.com | 2008 | Ithaca, United States | $72.72M | 109 | Instruments for automated molecular assays are developed using disposable cartridges. | |
| 64xbio.com | 2017 | San Francisco, United States | $59.65M | 18 | Cell and gene therapies for multiple diseases are developed. | |
| modulargenetics.com | 2000 | Woburn, United States | $7.5M | 7 | Proprietary automated systems for gene engineering are developed. |
Detailed competitors of Primity Bio
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Life Sciences Platforms & Tools
3 companies that operate in the same segment as Primity Bio (Life Sciences Platforms & Tools) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | |||
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | 1,111 | ||
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Primity Bio
Primity Bio was founded in 2008.
Primity Bio is headquartered in Santa Clara, United States. It is registered at Santa Clara, California, United States.
Peter Krutzik is the CEO of Primity Bio, as recorded in our data. They have also founded this company.
PrimityBio has developed a flowcytometry-based, multiparameter cell analysis system for high content screening with a focus on drug discovery applications. The companys platform performs single cell analysis at more than 10 parameters or markers per cell, at a rate of 5000 cells per second, with sensitivity in the range of 50 molecules per cell. Coupled with automation, the system can screen through 2000 compound wells per day to generate over 100,000 data points. The company also provides the Cytobank flow cytometry software which can analyze the generated data. The systems instrumentation includes a choice of flow cytometers (4, 5 and 6 laser BD LSR II flow cytometers with HTS sample units and up to 19 fluorescent channels, Fluidigm CyTOF Helios Mass Cytometer, BD Aria II Cell Sorter, Agilent VWorks-based automation platform, etc.
Primity Bio's top competitors include 64x Bio, Rheonix and Modular Genetics.
Primity Bio offers Biomarker Services, Genomics Services, Histopathology Services, Immune Monitoring, and Lab Logistics Services.
Yes. Primity Bio was acquired by CellCarta in August 2018.